282 related articles for article (PubMed ID: 12613196)
1. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
Paez J; Sellers WR
Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
[No Abstract] [Full Text] [Related]
2. Phosphoinositide signaling in urological disease.
Theodorescu D
J Urol; 2003 Jun; 169(6):2394-6. PubMed ID: 12771804
[No Abstract] [Full Text] [Related]
3. PI3K/Akt and apoptosis: size matters.
Franke TF; Hornik CP; Segev L; Shostak GA; Sugimoto C
Oncogene; 2003 Dec; 22(56):8983-98. PubMed ID: 14663477
[TBL] [Abstract][Full Text] [Related]
4. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
[TBL] [Abstract][Full Text] [Related]
5. Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
Ott VL; Cambier JC
Semin Immunol; 2002 Feb; 14(1):1-6. PubMed ID: 11884225
[No Abstract] [Full Text] [Related]
6. An essential role for protein synthesis in oncogenic cellular transformation.
Bader AG; Vogt PK
Oncogene; 2004 Apr; 23(18):3145-50. PubMed ID: 15094764
[TBL] [Abstract][Full Text] [Related]
7. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
8. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
9. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.
She QB; Solit DB; Ye Q; O'Reilly KE; Lobo J; Rosen N
Cancer Cell; 2005 Oct; 8(4):287-97. PubMed ID: 16226704
[TBL] [Abstract][Full Text] [Related]
10. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
11. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation.
Sharma M; Chuang WW; Sun Z
J Biol Chem; 2002 Aug; 277(34):30935-41. PubMed ID: 12063252
[TBL] [Abstract][Full Text] [Related]
13. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells.
Nielsen-Preiss SM; Silva SR; Gillette JM
J Cell Biochem; 2003 Dec; 90(5):964-75. PubMed ID: 14624456
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statins: acutely good, but chronically bad?
Schulz R
J Am Coll Cardiol; 2005 Apr; 45(8):1292-4. PubMed ID: 15837264
[No Abstract] [Full Text] [Related]
15. [PTEN expression in endometrial cancer and the prognosis].
Kanamori Y; Uegaki K; Kigawa J; Terakawa N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
[No Abstract] [Full Text] [Related]
16. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling.
Chuenkova MV; Furnari FB; Cavenee WK; Pereira MA
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9936-41. PubMed ID: 11481434
[TBL] [Abstract][Full Text] [Related]
17. The conserved PI3'K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila.
Scanga SE; Ruel L; Binari RC; Snow B; Stambolic V; Bouchard D; Peters M; Calvieri B; Mak TW; Woodgett JR; Manoukian AS
Oncogene; 2000 Aug; 19(35):3971-7. PubMed ID: 10962553
[TBL] [Abstract][Full Text] [Related]
18. Pten, a protean tumor suppressor.
Mutter GL
Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
[No Abstract] [Full Text] [Related]
19. Akt in prostate cancer: possible role in androgen-independence.
Ghosh PM; Malik S; Bedolla R; Kreisberg JI
Curr Drug Metab; 2003 Dec; 4(6):487-96. PubMed ID: 14683476
[TBL] [Abstract][Full Text] [Related]
20. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]